Users online: 2575    [ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2020, Volume : 13, Issue : 7
First page : ( 3246) Last page : ( 3248)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.00575.2

Fetal Hemoglobin (HbF) levels in Sickle cell anemia patients in Lattakia, Syria

Ahmad Rana I.*, Al-Barry Haider A., Salloum Salwa I.

Department of Laboratory Medicine, Faculty of Medicine, Al Andalus University for Medical Sciences, Al Qadmus, Tartus, Syria

*Corresponding Author E-mail: ranaad83@gmail.com

Online published on 10 August, 2020.


Sickle cell anemia (SCA) is a chronic hemolytic disorder. It is considered as a major health problem in Syria. The risk of this disease varies among patients worldwide. Fetal hemoglobin (HbF) decreases the severity of SCA by inhibiting the polymerization of sickle hemoglobin (HbS). The aim of this study is to determine the HbF levels in SCA patients. Blood samples were collected from 175 SCA patients. The level of HbF was more than 10%, High level of HbF in 126/175 Patients. The mean of HbF levels was 24.75± 18.8%, and varied according to age, gender, SCD complications. The relation between HbF and SCA complications is still unclear, therefore, more studies were recommended.



Sickle cell anemia, fetal hemoglobin, sickle hemoglobin, Syria.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
623,198,383 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.